Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole for xerostomia and laryngopharyngeal reflux in Sjögren's syndrome
KCT0008138Phase 4Withdrawn
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ilaprazole in Sjögren's syndrome, xerostomia, laryngopharyngeal reflux (LPR), sponsored by Il-Yang Pharmaceutical. Planned start Mar 2024; status: withdrawn.
02
Drugs
ilaprazole
03
Conditions
Sjögren's syndromexerostomialaryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on KCT0008138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008138.